Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

NCT03151499 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 409306
DRUG: Rifampicin

Sponsor

Boehringer Ingelheim